Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share

Market Share of Global Xerostomia (Dry Mouth Disease) Therapeutics Industry

The xerostomia therapeutics market is moderately competitive. Key players in the xerostomia (dry mouth disease) therapeutics market are focusing on the development of their product portfolio, acquisition of emerging players, and distribution agreements to increase their geographical presence. Some of the key players dominating the xerostomia therapeutics market are 3M, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Lupin, Parnell Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., and Synedgen, among others.

Xerostomia Dry Mouth Disease Therapeutics Market Leaders

1. GlaxoSmithKline PLC

2. Parnell Pharmaceuticals Inc.

3. Bausch Health Companies Inc.

4. 3M company

5. Quest Products Inc.

*Disclaimer: Major Players sorted in no particular order